Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells.
In conclusion, the results of the present study indicated that CTD impeded cell growth and migration by inhibiting PI3K/Akt/mTOR signaling in NSCLC, and promoted autophagy and apoptosis. CTD exhibited anticancer activity against NSCLC in vitro, revealing it as a potential candidate for the treatment of NSCLC.
PMID: 29731854 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Study